Medical News

RSS

Top-line data from Spectrum's SPI-1620 Phase 1 combination study on carcinoma

Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced that top-line data from part one of a two-part Phase 1 study of SPI-1620 in combination with docetaxel was presented in an oral presentation at the 12th International Conference on Endothelin, held in Cambridge, United Kingdom, from September 11-14, 2011. Part one of the study has been completed, while part two is ongoing.

19 Sep 2011

OptiScan's new bedside glucose monitoring system receives European CE Mark

OptiScan Biomedical Corporation, a developer of innovative continuous glucose monitoring systems for use in intensive care units (ICU), today announced that the company's OptiScanner Automatic Bedside Glucose Monitoring System has received CE Mark certification for use in the European Union.

19 Sep 2011

Inhibitex initiates INX-189 combination Phase 2 trial in HCV-infected genotype 2/3 patients

Inhibitex, Inc., announced today that it has recently commenced dosing in a 90-patient randomized, placebo controlled, treatment guided, Phase 2 clinical trial to evaluate the safety, tolerability and antiviral activity of INX-189 in combination with pegylated interferon and ribavirin in chronic HCV-infected genotype 2 and 3 treatment naïve patients.

19 Sep 2011

KYTHERA closes $37.4M Series D financing

KYTHERA Biopharmaceuticals, Inc., a privately-held biotechnology company focused on the development and commercialization of products in aesthetic medicine, today announced the closing of a $37.4M Series D financing.

19 Sep 2011

Aestus to develop ATx09-002 for treatment of neuropathic pain

Aestus Therapeutics, Inc. and Prosidion Ltd., a wholly owned subsidiary of Astellas Pharma Inc., announced today a license agreement providing Aestus with exclusive, world-wide rights to the Prosidion investigational product PSN-357.

19 Sep 2011

Shannon installs Toshiba's Infinix CF-i single plane vascular X-ray system

Performing cardiac catheterizations through the radial artery is proven to lower the risk of vascular complications, reduce major bleeding and improve patient recovery time when compared to femoral access. Shannon Medical Center, in San Angelo, Texas, installed Toshiba America Medical Systems, Inc.'s Infinix CF-i single plane vascular X-ray system to conduct radial interventions more easily and improve patient safety and outcomes while reducing costs.

19 Sep 2011

Patients allege doctors fail to properly explain risks of complications

In more than 70 per cent of legal disputes over informed consent, patients allege the doctor failed to properly explain the risks of complications, a University of Melbourne study published in the latest Medical Journal of Australia has found.

19 Sep 2011

Study investigates links between GWI and veterans' locations during war

Gulf War Illness (GWI)-the chronic health condition that affects about one in four military veterans of the 1991 Gulf War-appears to be the result of several factors, which differed in importance depending upon the locations where veterans served during the war, according to a Baylor University study.

19 Sep 2011

Researcher identifies genetic mutation responsible for adermatoglyphia

Like DNA, fingerprints are unique to each person or set of identical twins. That makes them a valuable identification tool for everything from crime detection to international travel. But what happens when the tips of our fingers are missing those distinctive patterns of ridges?

19 Sep 2011

ESMO honors three medical oncologists for cancer care and research

The European Society for Medical Oncology (ESMO) has honored three of Europe's leading medical oncologists with prestigious awards recognizing their achievements in clinical care and research.

19 Sep 2011

Capacity for learning in birds not linked to overall brain size

Call a bird "birdbrained" and they may call "fowl." Cornell University researchers have proven that the capacity for learning in birds is not linked to overall brain size, but to the relative size and proportion of their specific brain regions.

19 Sep 2011

Techulon signs distribution agreement with BioConcept for Glycofect

Techulon Inc., the leader in low-toxicity gene delivery has signed a distribution agreement with BioConcept of Allschwil, Switzerland.

19 Sep 2011

UMF sponsors second annual Hygiene Specialist Excellence award

Environmental Services Managers are encouraged to nominate the housekeeper of their choice for the second annual Hygiene Specialist Excellence award, which is sponsored by UMF Corporation, developer of the PerfectCLEAN Infection Prevention System.

19 Sep 2011

Spinifex initiates EMA401 Phase 2 trial in postherpetic neuralgia

Spinifex Pharmaceuticals, an Australian pain drug development company, today announced the first patients have been treated in its Phase 2 clinical trial of EMA401 in postherpetic neuralgia (PHN), a painful condition that develops in some patients following herpes zoster (shingles) and where existing therapy does not relieve pain in all individuals.

19 Sep 2011

Nutracheck launches UK's first weight loss App

The UK's first weight loss App that scans barcodes on food products has been launched by Nutracheck.co.uk.

19 Sep 2011

ESC urges European heads of state to prevent chronic non-communicable diseases

The European Society of Cardiology, through the European Chronic Disease Alliance (ECDA), has urged European heads of state "to show leadership" and long-term commitment to the prevention of chronic non-communicable diseases at today's "high level meeting" of the UN General Assembly in New York.

19 Sep 2011

Meda acquires exclusive licensing rights to Nalox from Moberg Derma

Meda has acquired exclusive licensing rights to Nalox (treatment of fungal nail infections/nail psoriasis) from Moberg Derma AB.

19 Sep 2011

Alkermes establishes business operations in Ireland

Alkermes plc today announced the establishment of its corporate operations in Ireland, with new headquarters located in Dublin. The company, including its headquarters and operations in Athlone, County Westmeath, has more than 450 employees based in Ireland and more than 1,200 employees worldwide.

19 Sep 2011

Karo Bio receives approval to initiate eprotirome phase III study in HeFH

Karo Bio AB has received approval from national regulatory authorities to start its phase III patient study with eprotirome, enabling the study to start as planned with an Investigators meeting in September.

19 Sep 2011

Low-dose anticholinergic drugs do not appear to cause cognitive impairment in dementia patients

Researchers whose findings on the detrimental impact of some common medicines on elderly people were widely reported earlier in the summer have found that taking a few of these medicines does not appear to cause further cognitive impairment in those already suffering from dementia.

19 Sep 2011